Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[An original thymoma]

Patrick Saint-Blancard1, Raoulin Soulard, Jean-Marc Delmas

  • 1Service d'Anatomie Pathologique, Hôpital d'Instruction des Armées Percy, France.

Annales De Pathologie
|July 19, 2002
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-Utility Analysis Alongside the GORTEC 2014-01 TPExtreme trial - Author Response to Letter to the Editor.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same author

Clinical diagnosis of spinal metastases: a narrative review.

Neuro-Chirurgie·2026
Same author

Hypofractionated split-course versus standard radiotherapy in frail older patients with head and neck squamous-cell carcinoma (ELAN-RT trial): a non-inferiority, multicentre, open-label, randomised controlled trial.

The lancet. Healthy longevity·2026
Same author

Cost-Utility Analysis Alongside the GORTEC 2014-01 TPExtreme Trial: TPEx Versus EXTREME as First-Line Treatment in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2025
Same author

Clinical and psychosocial characteristics of persistent finger post-traumatic segmentary exclusion syndrome: A descriptive study.

Hand surgery & rehabilitation·2025
Same author

NISCAHN: a phase II trial of nivolumab in patients with salivary gland carcinoma (Unicancer ORL-08).

BMJ oncology·2025